← 產業報告目錄
Electroceuticals Market Size, Share & Trends Analysis Report, By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants), By Type (Implantable Electroceutical Devices and Non-Invasive Electroceutical Devices), By Application, By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-19頁數 180報告編號 INSIGHTACE-0952cc42e2
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Electroceuticals Market worldwide was assessed at USD 19.08 billion. Analysts project it will surge to USD 32.40 billion by 2031, at a CAGR of 6.94% spanning 2024 to 2031.
Electroceuticals covers reshaping how healthcare entities approach this space.
The market's upward path is propelled by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Electroceuticals Market Snapshot
Chapter 4. Global Electroceuticals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
5.2.2. Cochlear Implants
5.2.3. Neuromodulators
5.2.3.1. Spinal Cord Stimulators
5.2.3.2. Deep Brain Stimulators
5.2.3.3. Sacral Nerve Stimulators
5.2.3.4. Vagus Nerve Stimulators
5.2.3.5. Gastric Electrical Stimulators
5.2.3.6. Transcutaneous Electrical Nerve Stimulator
5.2.3.7. Transcranial Magnetic Stimulators
5.2.3.8. Respiratory Electrical Stimulators
5.2.3.9. Trigeminal Nerve Stimulators
5.2.3.10. Responsive Neurostimulators
5.2.4. Retinal Implants
Chapter 6. Market Segmentation 2: by Type Estimates & Trend Analysis
6.1. by Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
6.2.1. Implantable Electroceutical Devices
6.2.2. Noninvasive Electroceutical Devices
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICD), By Application
7.2.1.1. Arrhythmia
7.2.1.2. Heart Failure
7.2.1.3. Other Cardiac Pacemakers & ICD Applications
7.2.2. Spinal Cord Stimulators Market, By Application
7.2.2.1. Failed Back Syndrome
7.2.2.2. Chronic Pain
7.2.2.3. Ischemia
7.2.3. Deep Brain Stimulators Market, By Application
7.2.3.1. Parkinson's Disease
7.2.3.2. Tremor
7.2.3.3. Depression
7.2.3.4. Other DBS Applications
7.2.4. Sacral Nerve Stimulators Market, By Application
7.2.4.1. Urine Incontinence
7.2.4.2. Fecal Incontinence
7.2.5. Vagus Nerve Stimulators Market, By Application
7.2.5.1. Epilepsy
7.2.5.2. Other VNS Applications
7.2.6. Gastric Electrical Stimulators Market, By Application
7.2.6.1. Gastroparesis
7.2.6.2. Obesity
7.2.7. Transcutaneous Electrical Nerve Stimulators Market, By Application
7.2.7.1. Treatment-Resistant Depression
7.2.7.2. Other TENS Applications
7.2.8. Transcranial Magnetic Stimulators Market, By Application
7.2.8.1. Depression
7.2.8.2. Migraine Headache
7.2.9. Trigeminal Nerve Stimulators, By Application
7.2.9.1. Attention Deficit Hyperactivity Disorder (ADHD)
7.2.9.2. Migraine
Chapter 8. Electroceuticals Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
8.1.2. North America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.1.3. North America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
8.2.2. Europe Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.2.3. Europe Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
8.3.2. Asia Pacific Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.3.3. Asia-Pacific Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
8.4.2. Latin America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.4.3. Latin America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
8.5.2. Middle East & Africa Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.5.3. Middle East & Africa Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Electroceuticals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
Abbott Laboratories, Inc. (US)
Medtronic Plc (Ireland)
Boston Scientific Corporation (Us)
Abbott
Livanova Plc
Cochlear Ltd.
Microport Scientific Corporation
Sonova
Nevro Corp.
Axonics, Inc.
Neuronetics
Electrocore, Inc.
Neuropace, Inc.
Biotronik
Medico S.R.L.
Zhejiang Nurotron Biotechnology Co., Ltd.
Med-El
Aleva Neurotherapeutics
Neurosigma, Inc.
Soterix Medical Inc.
Bioinduction (Amber Therapeutics)
Gimer Medical
Cefaly
Biocontrol Medical
Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們